593 related articles for article (PubMed ID: 28848053)
1. Antigen-Presenting Intratumoral B Cells Affect CD4
Bruno TC; Ebner PJ; Moore BL; Squalls OG; Waugh KA; Eruslanov EB; Singhal S; Mitchell JD; Franklin WA; Merrick DT; McCarter MD; Palmer BE; Kern JA; Slansky JE
Cancer Immunol Res; 2017 Oct; 5(10):898-907. PubMed ID: 28848053
[TBL] [Abstract][Full Text] [Related]
2. CD4+ T cells in cancer stroma, not CD8+ T cells in cancer cell nests, are associated with favorable prognosis in human non-small cell lung cancers.
Wakabayashi O; Yamazaki K; Oizumi S; Hommura F; Kinoshita I; Ogura S; Dosaka-Akita H; Nishimura M
Cancer Sci; 2003 Nov; 94(11):1003-9. PubMed ID: 14611679
[TBL] [Abstract][Full Text] [Related]
3. Increased levels of tumor-infiltrating lymphocytes are associated with improved recurrence-free survival in stage 1A non-small-cell lung cancer.
Horne ZD; Jack R; Gray ZT; Siegfried JM; Wilson DO; Yousem SA; Nason KS; Landreneau RJ; Luketich JD; Schuchert MJ
J Surg Res; 2011 Nov; 171(1):1-5. PubMed ID: 21571304
[TBL] [Abstract][Full Text] [Related]
4. CD20+ tumor-infiltrating lymphocytes have an atypical CD27- memory phenotype and together with CD8+ T cells promote favorable prognosis in ovarian cancer.
Nielsen JS; Sahota RA; Milne K; Kost SE; Nesslinger NJ; Watson PH; Nelson BH
Clin Cancer Res; 2012 Jun; 18(12):3281-92. PubMed ID: 22553348
[TBL] [Abstract][Full Text] [Related]
5. Prognostic effect of epithelial and stromal lymphocyte infiltration in non-small cell lung cancer.
Al-Shibli KI; Donnem T; Al-Saad S; Persson M; Bremnes RM; Busund LT
Clin Cancer Res; 2008 Aug; 14(16):5220-7. PubMed ID: 18698040
[TBL] [Abstract][Full Text] [Related]
6. Tumor-infiltrating lymphocytes predict response to chemotherapy in patients with advance non-small cell lung cancer.
Liu H; Zhang T; Ye J; Li H; Huang J; Li X; Wu B; Huang X; Hou J
Cancer Immunol Immunother; 2012 Oct; 61(10):1849-56. PubMed ID: 22456757
[TBL] [Abstract][Full Text] [Related]
7. Phenotypic analysis of T lymphocytes isolated from non-small-cell lung cancer.
Riemann D; Wenzel K; Schulz T; Hofmann S; Neef H; Lautenschläger C; Langner J
Int Arch Allergy Immunol; 1997 Sep; 114(1):38-45. PubMed ID: 9303329
[TBL] [Abstract][Full Text] [Related]
8. Cytokine biosynthesis by tumor-infiltrating T lymphocytes from human non-small-cell lung carcinoma.
Ortegel JW; Staren ED; Faber LP; Warren WH; Braun DP
Cancer Immunol Immunother; 2000 Feb; 48(11):627-34. PubMed ID: 10663610
[TBL] [Abstract][Full Text] [Related]
9. Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer.
Woo EY; Chu CS; Goletz TJ; Schlienger K; Yeh H; Coukos G; Rubin SC; Kaiser LR; June CH
Cancer Res; 2001 Jun; 61(12):4766-72. PubMed ID: 11406550
[TBL] [Abstract][Full Text] [Related]
10. Establishment of adoptive cell therapy with tumor infiltrating lymphocytes for non-small cell lung cancer patients.
Ben-Avi R; Farhi R; Ben-Nun A; Gorodner M; Greenberg E; Markel G; Schachter J; Itzhaki O; Besser MJ
Cancer Immunol Immunother; 2018 Aug; 67(8):1221-1230. PubMed ID: 29845338
[TBL] [Abstract][Full Text] [Related]
11. TIM-3 expression characterizes regulatory T cells in tumor tissues and is associated with lung cancer progression.
Gao X; Zhu Y; Li G; Huang H; Zhang G; Wang F; Sun J; Yang Q; Zhang X; Lu B
PLoS One; 2012; 7(2):e30676. PubMed ID: 22363469
[TBL] [Abstract][Full Text] [Related]
12. Lung tissue and tumour-infiltrating T lymphocytes in patients with non-small cell lung carcinoma and chronic obstructive pulmonary disease (COPD): moderate/severe versus mild stage of COPD.
Marc MM; Korosec P; Kern I; Sok M; Ihan A; Kosnik M
Scand J Immunol; 2007 Dec; 66(6):694-702. PubMed ID: 17949407
[TBL] [Abstract][Full Text] [Related]
13. Human tumor-infiltrating CD4+ T cells react to B cell lines expressing heat shock protein 70.
Yoshino I; Goedegebuure PS; Peoples GE; Lee KY; Eberlein TJ
J Immunol; 1994 Nov; 153(9):4149-58. PubMed ID: 7930618
[TBL] [Abstract][Full Text] [Related]
14. Phenotypic and functional analysis of tumor-infiltrating lymphocytes compared with tumor-associated lymphocytes from ascitic fluid and peripheral blood lymphocytes in patients with advanced ovarian cancer.
Santin AD; Hermonat PL; Ravaggi A; Bellone S; Roman JJ; Smith CV; Pecorelli S; Radominska-Pandya A; Cannon MJ; Parham GP
Gynecol Obstet Invest; 2001; 51(4):254-61. PubMed ID: 11408737
[TBL] [Abstract][Full Text] [Related]
15. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix.
Santin AD; Ravaggi A; Bellone S; Pecorelli S; Cannon M; Parham GP; Hermonat PL
Gynecol Oncol; 2001 Jun; 81(3):424-32. PubMed ID: 11371133
[TBL] [Abstract][Full Text] [Related]
16. Density of tumor-infiltrating FOXP3+ T cells as a response marker for induction chemoradiotherapy and a potential prognostic factor in patients treated with trimodality therapy for locally advanced non-small cell lung cancer.
Tao H; Shien K; Soh J; Matsuda E; Toyooka S; Okabe K; Miyoshi S
Ann Thorac Cardiovasc Surg; 2014; 20(6):980-6. PubMed ID: 24583705
[TBL] [Abstract][Full Text] [Related]
17. Multiplex B cell characterization in blood, lymph nodes, and tumors from patients with malignancies.
Zirakzadeh AA; Marits P; Sherif A; Winqvist O
J Immunol; 2013 Jun; 190(11):5847-55. PubMed ID: 23630345
[TBL] [Abstract][Full Text] [Related]
18. Tumor-infiltrating regulatory T cells inhibit endogenous cytotoxic T cell responses to lung adenocarcinoma.
Ganesan AP; Johansson M; Ruffell B; Yagui-Beltrán A; Lau J; Jablons DM; Coussens LM
J Immunol; 2013 Aug; 191(4):2009-17. PubMed ID: 23851682
[TBL] [Abstract][Full Text] [Related]
19. Phenotypes of lymphocytes infiltrating non-small cell lung cancer tissues and its variation with histological types of cancer.
Yoshino I; Yano T; Murata M; Miyamoto M; Ishida T; Sugimachi K; Kimura G; Nomoto K
Lung Cancer; 1993 Oct; 10(1-2):13-9. PubMed ID: 8069600
[TBL] [Abstract][Full Text] [Related]
20. Stromal CD4/CD25 positive T-cells are a strong and independent prognostic factor in non-small cell lung cancer patients, especially with adenocarcinomas.
Kayser G; Schulte-Uentrop L; Sienel W; Werner M; Fisch P; Passlick B; Zur Hausen A; Stremmel C
Lung Cancer; 2012 Jun; 76(3):445-51. PubMed ID: 22300751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
